237 related articles for article (PubMed ID: 14585155)
21. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
22. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
23. A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens.
Phetsuksiri B; Rudeeaneksin J; Supapkul P; Wachapong S; Mahotarn K; Brennan PJ
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):319-28. PubMed ID: 17052269
[TBL] [Abstract][Full Text] [Related]
24. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
25. A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae.
Honoré N; Roche PW; Grosset JH; Cole ST
Lepr Rev; 2001 Dec; 72(4):441-8. PubMed ID: 11826480
[TBL] [Abstract][Full Text] [Related]
26. Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.
Meyers WM; Marty AM
Drugs; 1991 Jun; 41(6):832-56. PubMed ID: 1715262
[TBL] [Abstract][Full Text] [Related]
27. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy.
Santos AR; Balassiano V; Oliveira ML; Pereira MA; Santos PB; Degrave WM; Suffys PN
Mem Inst Oswaldo Cruz; 2001 Nov; 96(8):1129-33. PubMed ID: 11784934
[TBL] [Abstract][Full Text] [Related]
28. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
[TBL] [Abstract][Full Text] [Related]
29. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
Grange JM; Beck JS; Abbot NC
Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
[No Abstract] [Full Text] [Related]
30. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
[TBL] [Abstract][Full Text] [Related]
31. [Advances in the chemotherapy of leprosy].
Grosset J
Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
[TBL] [Abstract][Full Text] [Related]
32. Facial tuberculoid leprosy: case report.
Ali K; Sittampalam G; Malik MA
Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of LSR/A15 gene for Mycobacterium leprae detection in leprosy tissues using the polymerase chain reaction.
Misra N; Ramesh V; Misra RS; Narayan NP; Colston MJ; Nath I
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):35-41. PubMed ID: 7730717
[TBL] [Abstract][Full Text] [Related]
34. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
35. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
36. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients.
Rafi A; Donoghue HD; Stanford JL
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718
[TBL] [Abstract][Full Text] [Related]
37. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
38. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
39. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy.
Jamil S; Keer JT; Lucas SB; Dockrell HM; Chiang TJ; Hussain R; Stoker NG
Lancet; 1993 Jul; 342(8866):264-8. PubMed ID: 8101301
[TBL] [Abstract][Full Text] [Related]
40. Leprosy: a review of laboratory and therapeutic aspects--part 2.
Lastória JC; Abreu MA
An Bras Dermatol; 2014; 89(3):389-401. PubMed ID: 24937811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
